Cargando…
Burden of Hyperglycemia in Patients Receiving Corticosteroids for Severe COVID-19
Although corticosteroid therapy is the standard of care for all patients hospitalized with severe coronavirus disease 2019 (COVID-19), the studies demonstrating the mortality–benefit ratio of corticosteroids were limited to fully evaluate their adverse effects. To determine the severity of corticost...
Autores principales: | Fetters, Kirk B., Judge, Stephen P., Daar, Eric S., Hatlen, Timothy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359482/ https://www.ncbi.nlm.nih.gov/pubmed/35966031 http://dx.doi.org/10.1016/j.mayocpiqo.2022.07.004 |
Ejemplares similares
-
280. Burden of Hyperglycemia in Patients Receiving Dexamethasone for Severe COVID-19
por: Fetters, Kirk B, et al.
Publicado: (2021) -
1526. Hospitalized Patients with HIV – Defining the Population and the Impact of Barriers to Care
por: Hatlen, Timothy, et al.
Publicado: (2023) -
Corticosteroids in diabetes patients infected with COVID-19
por: Deng, Fuxue, et al.
Publicado: (2020) -
Acute Hyperglycemia Due to Topical Corticosteroid Administration
por: Sue, Laura Y., et al.
Publicado: (2019) -
Pitfalls of Early Systemic Corticosteroids Home Therapy in Older Patients with COVID-19 Pneumonia
por: Okoye, Chukwuma, et al.
Publicado: (2022)